Mauri lab based @UCL. Our research interests include B cells, regulatory B cells and their roles in autoimmune disease and cancer. #lupus #arthritis #cancer

London, England
Joined March 2016
Thrilled to share our new preprint! 🎉 We uncover a novel subset of double negative (DN1) Bregs expanded in RCC, located within immature tertiary lymphoid structures, that suppress cytotoxic T cell activation. Led by @DrZaraBaig & Izzy, with support from all our collaborators.
2
3
17
1,024
📢 This open‑access study identifies PSMB8 as a biomarker predicting proton pump inhibitor response in paediatric eosinophilic esophagitis, supporting more personalized treatment decisions. 🔗 vist.ly/5ixam
1
1
136
This open‑access study shows the β‑blocker nebivolol prevents T‑cell exhaustion and boosts cytotoxicity against breast cancer cells via β₂‑adrenergic receptor–dependent signalling, highlighting a potential new immunomodulatory strategy. vist.ly/5h4ta
1
3
191
Join us in celebrating 60 years of pioneering clinical and translational immunology research! Explore our special collection showcasing the most-cited and widely-read articles that shaped our legacy: vist.ly/5hjvm #CEIat60
1
1
140
🧬 How does ageing with frailty reshape immune responses? This open‑access study links altered neutrophil signalling to impaired chemotaxis and increased ROS/NET production, highlighting key features of inflammageing. 👉 vist.ly/5ihau #ImmuneAgeing26
1
6
156
A great day at #LIG26, exploring how the microbiome, diet, pollution and stress affect immunity. Lots of fascinating research being shared today 🙂 If you're here, free to come and talk to our Journals Manager, Laura Franklin, about publishing your research in the BSI journals!
2
5
662
🔬 New research suggests that stronger IgA and IgG antibody responses may help protect against active TB. Elevated salivary IgA also highlights the potential importance of mucosal immunity. doi.org/10.1093/cei/uxaf001
1
2
147
IFNγ from activated CD4⁺ T cells is a key driver of B‑cell differentiation and autoantibody production in IMQ‑induced lupus mice. IFNγ deficiency dramatically reduced disease features, a promising immune pathway for future SLE therapies. doi.org/10.1093/cei/uxaf079
2
3
190
What does living past 105 look like immunologically? Increased Vδ1 TEMRA, CD8+ T and NK cells suggest a resilient immune system shaped by lifelong adaptation. 🧬 doi.org/10.1093/cei/uxad132
1
2
155
📣 Excited about engaging the public in #immunology? Apply for the BSI Communication & Engagement Grant! Up to £1,000 for projects that inspire, educate and build trust in science. Deadline: 1 October 2026! Apply here: bit.ly/3Y9j8gm
2
6
713
In Sjögren’s syndrome, salivary gland epithelial cells act not just as targets but as drivers of autoimmune inflammation. Their altered signalling and antigen‑presenting features can shape and sustain immune dysregulation. 🔗 doi.org/10.1093/cei/uxaf078
1
3
195
🧬 Could extracellular microvesicles help track rheumatoid arthritis activity? Anti-TNFα therapy reduced EMVs carrying disease-associated protein modifications, alongside improvements in disease activity, highlighting their potential as biomarkers. 🔬 🔗 doi.org/10.1093/cei/uxag044
2
3
198
Targeting T-cell integrins has become an important therapeutic strategy for autoimmune and inflammatory diseases. This review covers the biology of integrins and the latest advances in integrin-targeting treatments. 🔗 doi.org/10.1093/cei/uxad093
1
3
175
Altered B-cell homeostasis and elevated IL10/TNFA expression in #CIDP suggest chronic humoral immune activation. Immune markers also correlated with nerve fiber loss and disability, highlighting potential biomarkers of disease activity. doi.org/10.1093/cei/uxad103 #Neurology
1
1
167
Could the environment hold the key to better immune therapies? 🌍 #LIG26 Join us in London this September to explore how diet, the microbiome, pollution and stress influence immunity, and open new avenues for prevention and treatment. Register now: immunology.org/events/signal…
1
4
274
🧬 New insight into rituximab resistance: CD40L and IL-4 shield B cells from NK cell-mediated killing via the HLA-E/NKG2A and HLA/KIR inhibitory pathways. Targeting these checkpoints could enhance B-cell depletion in autoimmune disease. 📖 doi.org/10.1093/cei/uxag001
2
2
159
🧬 In a murine arthritis model, blockade of TIM-1 or TIM-3 reduced disease severity, inflammatory cytokines (IL-6, IL-17A, TNF-α), and joint damage, highlighting both receptors as promising therapeutic targets in rheumatoid arthritis. 📖 doi.org/10.1093/cei/uxae056
2
4
291
Important CIDP research shows significant changes in circulating B‑cell subsets and elevated IL10/TNFA expression, correlating with disability scores and nerve fiber density. Valuable insights for understanding disease activity. 📄 doi.org/10.1093/cei/uxad103
1
2
107